GOLDMAN SACHS GROUP INC - KALOBIOS PHARMACEUTICALS INC ownership

KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 24 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KALOBIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$7,0000.0%14,456
+7.1%
0.00%
Q1 2015$7,000
-70.8%
13,494
-0.9%
0.00%
Q4 2014$24,000
+20.0%
13,613
+4.0%
0.00%
Q3 2014$20,000
-48.7%
13,086
-24.4%
0.00%
Q2 2014$39,000
-84.9%
17,314
-69.6%
0.00%
Q3 2013$258,00057,0190.00%
Other shareholders

There were no reported owners of KALOBIOS PHARMACEUTICALS INC in Q1 2015.

NameSharesValueWeighting ↓
View complete list of KALOBIOS PHARMACEUTICALS INC shareholders